New tech and quality chiefs signal Integra’s next growth push

robot
Abstract generation in progress

Integra LifeSciences (Nasdaq: IART) announced three key executive appointments aimed at driving future growth and innovation. Teshtar Elavia was named the first Chief Technology Officer, Michael Hutchinson as Executive Vice President and Chief Legal Officer, and Kerri DiPietro as Corporate Vice President and Chief Quality Officer. These appointments are expected to enhance the company’s R&D, legal, compliance, and quality systems, building on recent positive regulatory and market developments.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)